Read Gilead’s Q1 2012 Financial
Tear Sheet

Print Page |

E-mail Page | Financial Tear Sheet

Financial Tear Sheet

Webcast - Live
Gilead Sciences at Bank of America Merrill Lynch Health Care Conference
05/16/12 at 3:40 p.m. PT

Webcast - Replay
Gilead Sciences Annual Shareholder Meeting 2012
05/10/12 at 10:00 a.m. PT

There are currently no items available.

Corporate Profile

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Asia Pacific.

GILD (Common Stock)
Exchange	NASDAQ (US Dollar)
Price	$51.58
Change (%)	0.29 (0.56%)
Volume	6,719,997
Data as of 05/16/12 4:00 p.m. ET Minimum 20 minute delay Refresh quote

Recent News

More >>

Date	Title
05/11/12	FDA Advisory Committee Supports Approval of Gilead’s Once-Daily Quad Single Tablet Regimen for HIV
05/10/12	FDA Advisory Committee Supports Approval of Gilead’s Truvada® for Reducing the Risk of Acquiring HIV
05/08/12	Gilead Sciences to Present at the Bank of America Merrill Lynch 2012 Health Care Conference on Wednesday, May 16

Upcoming Events

More >>

There are currently no events scheduled.

Most Viewed Links

Updated 05/16/12

1.	SEC Filings
2.	Stock Quote
3.	Annual Reports
4.	Gilead Sciences Announces First Quarter 2012 Financial Results
5.	Fundamentals - Snapshot

* Data collected 04/23/12 - 04/30/12

Receive E-mail Alerts

Sign up to receive e-mail alerts whenever Gilead Sciences posts new information to the site. Just enter your e-mail address and click Submit.

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.